Omni Health Progress Unknown on Plans to Open CBD Anti-Aging Clinic by December
Miami-based Omni Health (OTC:OMHE), a healthcare company developing cannabis-based pharmaceuticals and anti-aging products, announced plans last February 2018 to open a clinic in Miami by December 2018 focused on anti-aging and aesthetic treatments. However, no news has followed, leaving investors with no idea if progress is underway.
The company has 1.14 billion shares outstanding and a stock price currently at US$ 0.004.
Omni said last February that it would lease its first facility in South Miami. The facility would offer anti-aging regenerative medicine solutions. The following were among treatments to be available:
- Bioidentical hormone therapy
- Medical weight loss management
- Nutrient supplements
- Detoxification
- I.V. Nutritional Therapy
- Wellness coaching
- Therapies for insomnia, migraines, and stress
- Stem Cell Regeneration Treatments
The market research firm Global Industry Analysts estimated that a baby boomer-fueled consumer base “seeking to keep the dreaded signs of aging at bay” will push the US market for anti-aging products from $80 billion now to more than $114 billion by 2020.
Omni Health claimed last February that it plans to open the new facility in December 2018 with the goal of opening a network of clinics nationwide and becoming a leader in anti-aging medicine and integrative health management. Omni further claimed that it anticipates pro-forma annual revenue of $7,500,000 per clinic.
With no news from Omni, it is not surprising that the company’s stock price has steadily drifted down over the year.
Source Omni press release Feb 28, 2018
Omni Health Progress Unknown on Plans to Open CBD Anti-Aging Clinic by December
About Cannin.com: Your Marijuana Stocks Resource
Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.
Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?
Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In
